GOSSELIES, Belgium–(BUSINESS WIRE)–Regulatory News: BONE THERAPEUTICS (Brussels:BOTHE) (Paris:BOTHE), the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, today announces it has been granted EUR 3 million in non-dilutive funding from